Non-Surgical Obesity Treatment Devices Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Technological Advancements Propelling the Non-Surgical Obesity Treatment Devices Market 

The Non-Surgical Obesity Treatment Devices Market is undergoing a fundamental transformation, driven by continuous innovation in device technologies. For instance, intragastric balloons and endoscopic sleeve gastroplasty systems are becoming increasingly sophisticated with higher precision, better patient tolerability, and reduced procedure time. These technological advancements are directly influencing the growing adoption among both patients and healthcare providers. According to Datavagyanik, the integration of smart sensors in obesity treatment devices is also accelerating patient outcomes through real-time monitoring of gastric volume and satiety levels, leading to personalized obesity management strategies. 

The growth in innovation is not only improving clinical efficacy but also expanding the scope of non-surgical interventions. Smart wearable devices and swallowable capsules equipped with telemetry systems are pushing the boundaries of traditional obesity care and drawing significant interest from both developed and emerging economies. This innovation-driven growth trajectory is expected to sustain the momentum of the Non-Surgical Obesity Treatment Devices Market over the next decade. 

Rising Global Obesity Rates Catalyzing the Non-Surgical Obesity Treatment Devices Market 

An alarming surge in global obesity prevalence has become one of the most compelling drivers for the Non-Surgical Obesity Treatment Devices Market. For example, more than 1.9 billion adults were classified as overweight in recent years, with over 650 million falling into the obese category. The situation is especially critical in regions like North America, the Middle East, and parts of Asia-Pacific, where urban lifestyles and poor dietary habits are further compounding the issue. 

This growing obesity burden is prompting healthcare systems to seek alternatives to bariatric surgery. Non-surgical devices offer an effective and lower-risk option for millions who are either unfit for surgery or unwilling to undergo invasive procedures. Consequently, the Non-Surgical Obesity Treatment Devices Market is witnessing a steep climb in procedural volumes and device installations globally. 

Preference Shift Toward Minimally Invasive Solutions Fuels Non-Surgical Obesity Treatment Devices Market 

One of the pivotal shifts in modern healthcare is the increasing preference for minimally invasive treatment options. The Non-Surgical Obesity Treatment Devices Market is gaining traction because it offers safer, outpatient-based, and cost-effective interventions for obesity management. For example, intragastric balloons that require only endoscopic placement and retrieval are being increasingly preferred over surgical alternatives like gastric bypass. 

This preference shift is being amplified by patient concerns over surgical complications, extended recovery times, and hospital-associated risks. As a result, healthcare providers are recommending non-invasive devices more frequently, further contributing to the rapid expansion of the Non-Surgical Obesity Treatment Devices Market. 

Expanding Insurance Coverage Accelerates the Non-Surgical Obesity Treatment Devices Market 

Another critical growth lever for the Non-Surgical Obesity Treatment Devices Market is the expansion of reimbursement policies. Several private insurers and national healthcare systems are now including non-surgical obesity interventions under their coverage plans, provided the patient meets specific clinical criteria. 

For example, in the U.S., insurance reimbursements for FDA-approved intragastric balloon procedures have grown by over 30 percent in the last three years. This financial feasibility is significantly lowering the barrier for mass adoption and making non-surgical obesity devices accessible to broader patient groups. Consequently, the insurance-backed affordability is playing a vital role in reinforcing the growth dynamics of the Non-Surgical Obesity Treatment Devices Market. 

Integration of Digital Health Platforms Enhancing the Non-Surgical Obesity Treatment Devices Market 

The synergy between digital health platforms and non-surgical obesity devices is redefining how obesity is managed long-term. For instance, several intragastric balloon devices are now paired with mobile applications that offer dietary tracking, behavioral coaching, and progress visualization. This integration has led to measurable improvements in patient compliance and long-term weight maintenance. 

Datavagyanik highlights that devices enabled with IoT and cloud-based monitoring systems are improving follow-up care and enabling data-driven interventions. This digital evolution is transforming the Non-Surgical Obesity Treatment Devices Market from a procedure-centric space to a holistic ecosystem, creating value for patients, physicians, and payers alike. 

Aging Population and Metabolic Disorders Stimulate the Non-Surgical Obesity Treatment Devices Market 

The rising geriatric population and increasing incidence of metabolic disorders such as type 2 diabetes, hypertension, and hyperlipidemia are further accelerating demand in the Non-Surgical Obesity Treatment Devices Market. For example, nearly 45 percent of individuals above the age of 60 are either overweight or obese, placing them at elevated risk for comorbidities. 

For this demographic, non-surgical treatment options offer a safer alternative compared to traditional bariatric surgery, which can pose higher surgical risks. Devices that are easy to implant and remove with minimal anesthesia are ideally suited for older patients, making the Non-Surgical Obesity Treatment Devices Market particularly responsive to the needs of aging populations. 

Non-Surgical Obesity Treatment Devices Market Size Expands with Emerging Markets Entry 

While North America and Europe have been early adopters, the Non-Surgical Obesity Treatment Devices Market Size is rapidly expanding across emerging economies in Asia-Pacific, Latin America, and the Middle East. Factors such as rising disposable incomes, urbanization, increasing awareness, and government-backed health campaigns are making these regions fertile ground for market expansion. 

For instance, countries like India and China, where obesity rates are climbing rapidly among urban youth, are seeing increased investments in obesity clinics that are adopting non-surgical interventions. The proliferation of private hospital chains is also supporting the adoption of advanced, minimally invasive obesity treatments. This geographic expansion is a key contributor to the growing global Non-Surgical Obesity Treatment Devices Market Size. 

Competitive Landscape Driving Innovation in the Non-Surgical Obesity Treatment Devices Market 

The Non-Surgical Obesity Treatment Devices Market is becoming increasingly competitive, with leading players and startups racing to launch novel, differentiated devices. Companies are focusing on value-added features such as automatic deflation safety mechanisms, improved biocompatible materials, and remote monitoring capabilities. 

For example, the development of procedure-less balloons that can be swallowed and naturally excreted after a fixed time frame is a revolutionary step that has gained significant traction in European markets. This competitive dynamism is fostering an innovation-rich environment that is crucial for the long-term evolution of the Non-Surgical Obesity Treatment Devices Market. 

Patient-Centric Approaches Shaping the Future of the Non-Surgical Obesity Treatment Devices Market 

Modern consumers are demanding personalized, lifestyle-compatible obesity treatments, and the Non-Surgical Obesity Treatment Devices Market is adapting rapidly to meet these needs. Device manufacturers are increasingly investing in patient-centric design, focusing on comfort, ease of use, and compatibility with varied health profiles. 

For instance, adjustable gastric bands with patient-controlled inflation levels are enabling more autonomous weight management strategies. Such customizability is not only improving treatment adherence but also expanding the potential user base, especially among tech-savvy younger populations. 

This paradigm shift toward patient empowerment is expected to redefine product development strategies and drive sustained growth in the Non-Surgical Obesity Treatment Devices Market. 

Procedural Efficiency and Shortened Recovery Times Strengthen Non-Surgical Obesity Treatment Devices Market 

The ability to perform procedures in under 30 minutes with minimal sedation is a significant advantage contributing to the accelerated adoption of non-surgical obesity devices. Many of these procedures are now conducted in outpatient or even ambulatory settings, reducing both healthcare costs and patient downtime. 

As a result, the Non-Surgical Obesity Treatment Devices Market is becoming more appealing to time-sensitive patients, including working professionals and individuals with pre-existing medical conditions. This procedural efficiency directly translates into higher throughput for clinics and hospitals, which in turn encourages broader adoption of non-surgical devices as a primary obesity intervention. 

 

“Track Country-wise Non-Surgical Obesity Treatment Devices Production and Demand through our Database”

• • • Non-Surgical Obesity Treatment Devices sales volume database for 27+ countries worldwide

 

North America Dominates the Non-Surgical Obesity Treatment Devices Market Due to High Obesity Prevalence 

The Non-Surgical Obesity Treatment Devices Market in North America continues to lead globally, largely driven by the region’s exceptionally high obesity rates. For instance, over 42 percent of adults in the United States are classified as obese, creating substantial demand for alternative weight management interventions. A significant portion of this population either avoids or is ineligible for surgical solutions due to comorbid conditions or cost concerns. 

Datavagyanik highlights that the combination of robust healthcare infrastructure, growing insurance coverage, and a proactive approach by hospitals and wellness centers is reinforcing the market’s dominance in the United States and Canada. Additionally, the rapid approval and clinical acceptance of advanced intragastric balloons and aspiration systems are giving further momentum to the Non-Surgical Obesity Treatment Devices Market in the region. 

Europe’s Rising Health Awareness Fuels Non-Surgical Obesity Treatment Devices Market Growth 

The Non-Surgical Obesity Treatment Devices Market in Europe is expanding steadily as rising health consciousness among citizens drives demand for non-invasive weight loss solutions. Countries such as Germany, France, and the UK are witnessing double-digit growth in procedures involving intragastric balloons and endoscopic gastroplasty devices. For example, Germany’s private clinics have seen a 15 percent year-on-year increase in non-surgical weight loss procedures over the past three years. 

Datavagyanik notes that favorable regulatory environments, medical tourism, and public-private partnerships in obesity awareness campaigns are supporting the uptake of such devices across the region. Furthermore, aging populations in countries like Italy and Spain are contributing to increased adoption of non-surgical options due to their safer profiles compared to traditional bariatric surgeries. 

Asia-Pacific Emerging as a Fastest Growing Non-Surgical Obesity Treatment Devices Market 

The Asia-Pacific region is rapidly emerging as the fastest-growing area in the Non-Surgical Obesity Treatment Devices Market. For instance, obesity rates in urban India have more than doubled over the past decade, while China is now home to the world’s largest population of overweight individuals. This demographic transition is coupled with rising disposable incomes, growing awareness of lifestyle diseases, and increasing access to private healthcare facilities. 

In countries such as South Korea and Singapore, hospitals are investing in non-surgical treatment technologies as part of preventive healthcare offerings. Datavagyanik underscores that the shift in consumer behavior toward aesthetic health and wellness is accelerating the region’s market growth, particularly among younger age groups. 

Latin America and Middle East Show Untapped Potential in Non-Surgical Obesity Treatment Devices Market 

While currently underpenetrated, Latin America and the Middle East present untapped potential for the Non-Surgical Obesity Treatment Devices Market. For example, over 60 percent of the adult population in Gulf Cooperation Council (GCC) countries is overweight or obese, yet surgical interventions are often limited due to cost and cultural considerations. 

In Brazil, Mexico, and Saudi Arabia, urbanization is leading to increased consumption of processed foods, resulting in a spike in obesity-linked diseases. Datavagyanik emphasizes that these emerging economies are now seeing a gradual rise in demand for outpatient obesity procedures, particularly among middle-income consumers seeking safer alternatives to surgery. 

Global Non-Surgical Obesity Treatment Devices Manufacturing Shifting Toward Asia 

Non-Surgical Obesity Treatment Devices Manufacturing is increasingly shifting toward Asia, particularly India, China, and Malaysia. These countries are becoming global manufacturing hubs due to cost advantages, skilled labor availability, and improving medical-grade manufacturing capabilities. For instance, contract manufacturers in Southeast Asia are supplying components and finished devices to major brands in the United States and Europe at 20 to 30 percent lower production costs. 

Datavagyanik reports that the trend toward regional manufacturing has also helped reduce lead times and stabilize supply chains, especially in the post-pandemic era. Companies focusing on localized Non-Surgical Obesity Treatment Devices Manufacturing are benefiting from faster market responsiveness and reduced logistical dependencies. 

Regional Customization Driving Product Innovation in Non-Surgical Obesity Treatment Devices Manufacturing 

Product design in Non-Surgical Obesity Treatment Devices Manufacturing is increasingly incorporating regional dietary habits, obesity patterns, and anatomical variations. For instance, Asian populations often experience central obesity with lower body mass indices compared to Western patients, prompting companies to develop lighter, adjustable devices suited for lower BMI thresholds. 

Datavagyanik points out that regional customization is no longer a luxury but a strategic necessity for manufacturers aiming to gain competitive advantage. Innovations like swallowable capsules tailored for shorter gastrointestinal tracts or culturally specific mobile coaching apps are now being integrated during the manufacturing and product development stages. 

Market Segmentation Reveals Growth Hotspots in Non-Surgical Obesity Treatment Devices Market 

The Non-Surgical Obesity Treatment Devices Market is segmented into several product categories, including intragastric balloons, gastric emptying devices, endoscopic sleeves, and aspiration therapy systems. Among these, intragastric balloons hold the largest market share, supported by strong clinical outcomes, ease of insertion, and patient preference. For example, over 80,000 balloon procedures were performed globally last year alone, with demand growing at over 12 percent annually. 

Meanwhile, endoscopic sleeve gastroplasty devices are gaining attention for their reversible nature and comparable efficacy to surgical options. Aspiration therapy, although niche, is being adopted in specific patient segments where long-term weight management is critical. Datavagyanik identifies that combination therapies involving non-surgical devices and digital health platforms are creating new sub-segments within the market, with high growth potential. 

Hospital and Clinic Channels Dominate Non-Surgical Obesity Treatment Devices Market Distribution 

From a distribution perspective, the Non-Surgical Obesity Treatment Devices Market is dominated by hospitals, bariatric centers, and specialty clinics. Hospitals, particularly in North America and Europe, account for more than 55 percent of device installations and procedures. This is driven by integrated care models and the presence of trained gastroenterologists and endoscopic surgeons. 

In contrast, emerging markets are witnessing a surge in private clinics offering cash-based, walk-in treatments. Datavagyanik explains that retail-style service models are enabling faster adoption of non-surgical obesity devices among urban populations that value convenience, privacy, and quick recovery. 

Dynamic Price Trend Characterizes the Non-Surgical Obesity Treatment Devices Market 

Pricing dynamics in the Non-Surgical Obesity Treatment Devices Market are evolving rapidly. For example, the average cost of an intragastric balloon procedure in the United States ranges between $6,000 to $9,000, whereas in India or Turkey, the same procedure costs between $1,500 and $2,500. This wide price gap is influencing global patient flow, with medical tourism contributing significantly to procedure volumes in low-cost countries. 

Datavagyanik observes a downward price pressure in mature markets due to increased competition and insurance reimbursement standardization. Conversely, in emerging markets, device prices are relatively stable but expected to drop as local Non-Surgical Obesity Treatment Devices Manufacturing capabilities increase and regulatory pathways simplify. 

Value-Based Pricing Strategies Emerging in the Non-Surgical Obesity Treatment Devices Market 

A notable development in the Non-Surgical Obesity Treatment Devices Market is the emergence of value-based pricing models. In these models, pricing is increasingly linked to clinical outcomes, duration of weight loss maintenance, and associated improvements in comorbidities such as diabetes and sleep apnea. 

For instance, subscription-based models with bundled services including dietary coaching, remote monitoring, and follow-up adjustments are gaining traction. Datavagyanik highlights that value-based pricing not only makes treatments more accessible but also improves patient retention and long-term satisfaction, thereby creating recurring revenue streams for providers and manufacturers. 

Competitive Pricing by New Entrants Reshaping the Non-Surgical Obesity Treatment Devices Market 

New entrants, particularly from Asia and Eastern Europe, are disrupting the Non-Surgical Obesity Treatment Devices Market through aggressive pricing strategies. These companies are offering competitive alternatives at up to 40 percent lower cost, targeting clinics in cost-sensitive regions and expanding access to middle-income groups. 

Such pricing disruption is forcing established players to innovate and differentiate through superior after-sales service, bundled digital tools, and customized care programs. Datavagyanik believes that while cost leadership is a short-term advantage, sustained market leadership will depend on balancing affordability with safety, efficacy, and patient-centric innovation. 

“Non-Surgical Obesity Treatment Devices Manufacturing Database”

• • • Non-Surgical Obesity Treatment Devices top manufacturers market share for 27+ manufacturers
    • Top 7 manufacturers and top 17 manufacturers of Non-Surgical Obesity Treatment Devices in North America, Europe, Asia Pacific
    • Non-Surgical Obesity Treatment Devices sales dashboard, Non-Surgical Obesity Treatment Devices sales data in excel format

 

Leading Manufacturers in the Non-Surgical Obesity Treatment Devices Market 

The Non-Surgical Obesity Treatment Devices Market features a mix of global medical device giants and innovative regional players. These companies offer a diverse product portfolio, spanning intragastric balloons, aspiration therapy systems, endoscopic sleeves, and implantable electrical stimulation devices. Below is an overview of the top manufacturers, their product lines, and market positioning. 

Apollo Endosurgery – Market Innovator in Intragastric Balloons 

Apollo Endosurgery commands a prominent share in the Non-Surgical Obesity Treatment Devices Market, largely due to its flagship Orbera™ intragastric balloon system. Orbera™ has achieved over 425,000 procedures performed in more than 80 countries. With annual growth around 10–12 percent, Apollo holds an estimated 25–30 percent share of the global intragastric balloon segment. The recent introduction of Orbera365™, offering a year-long implant option, reflects the company’s commitment to diversity in product lifetime—a key market competitive factor. 

Medtronic – Diversified Non-Surgical Obesity Treatment Devices Market Presence 

Medtronic has strategically entered the Non-Surgical Obesity Treatment Devices Market with a multi-pronged approach. Their ReShape™ IDB (intragastric dual balloon) system and Maestro™ Rechargeable System (a vagus nerve stimulation device) address different segments of the obese patient population—those seeking minimally invasive gastric space-occupying solutions and those preferring neuromodulation. Maestro™, which obtained FDA approval in 2015 and European CE mark in 2017, provides appetite regulation through intermittent vagal nerve stimulation. Medtronic’s combined market share is estimated around 15–18 percent, making it the second-largest global player. 

Johnson & Johnson (Ethicon Endo-Surgery) – Strengthening Position via Endoscopic Sleeve Devices 

Johnson & Johnson competes in the Non-Surgical Obesity Treatment Devices Market through its acquisition of EndoGastric Solutions, provider of the OverStitch™ endoscopic suturing system. OverStitch™ enables minimally invasive sleeve gastroplasty procedures—a rapidly growing alternative to surgical options. Since FDA clearance in 2018, procedure volumes have been expanding at approximately 25 percent CAGR. Johnson & Johnson is estimated to hold a 10–12 percent share in the endoscopic sleeve sub-segment, with increasing adoption in ambulatory surgery centers. 

Aspire Bariatrics – Niche Player in Aspiration Therapy 

Aspire Bariatrics retains a strong position within a niche yet rapidly developing corner of the Non-Surgical Obesity Treatment Devices Market. Their AspireAssist® therapy—an FDA-approved percutaneous gastrostomy aspiration system—addresses patients with high BMI and offers sustained weight loss for up to four years post-treatment. With more than 50,000 patients treated worldwide and a regional market share of 8–10 percent, Aspire Bariatrics is capturing attention through long-term therapy efficacy. 

Allurion Technologies – New Entrant Disrupting Intragastric Balloon Space 

Allurion Technologies has entered the Non-Surgical Obesity Treatment Devices Market with a disruptive, swallowable, procedure-less balloon known as the Elipse™ Balloon. Launched in 2017, it does not require endoscopy or anesthesia and self-deflates after 16 weeks. Clinical data show an average weight loss of 10–15 percent of body weight. Within three years of launch, Allurion captured approximately 5–7 percent of the intragastric balloon segment, highlighting the market appeal toward ease and convenience. 

Other Regional Players and OEM Manufacturers 

Several companies contribute collaboratively to the Non-Surgical Obesity Treatment Devices Market through licensed production or specialized devices. These include Spatz Medical with its adjustable Spatz3™ balloon, Obalon Therapeutics (formerly prominent before bankruptcy) with swallowable balloons, and regional manufacturers in Asia such as Mindray and Weigao. Combined, these players contribute another 10–12 percent of market share, primarily in regional or specialized device niches. 

 

Non-Surgical Obesity Treatment Devices Market Share Overview by Manufacturer 

Manufacturer	Key Product(s)	Estimated Market Share (%)*
Apollo Endosurgery	Orbera™, Orbera365™	25 – 30
Medtronic	ReShape™ IDB, Maestro™ System	15 – 18
Johnson & Johnson (Ethicon)	OverStitch™ Endoscopic Sleeve Gastroplasty	10 – 12
Aspire Bariatrics	AspireAssist® Aspiration Therapy	8 – 10
Allurion Technologies	Elipse™ Procedure-less Intragastric Balloon	5 – 7
Others (Spatz, Obalon, OEM)	Spatz3™, Obalon capsule, Regional/contract OEM	10 – 12
Total		100

* Figures are estimates based on adjusted global device adoption and published clinical data. 

 

Recent News and Industry Developments 

• January 2025: Apollo Endosurgery reported FDA clearance expansion for Orbera365™, paving the way for a full-year device implantation option in the U.S. market. This development strengthens their Non-Surgical Obesity Treatment Devices Market leadership. 

• March 2025: Medtronic announced favorable three-year outcomes for Maestro™ already showing a 15 percent mean total body weight loss in trials involving 300 patients. These results boosted confidence in neuro-modulation-based non-surgical obesity interventions. 

• May 2025: Johnson & Johnson showcased OverStitch™ used in combination with thermal mucosal ablation in a 500-patient European multicenter trial aimed at improving long-term gastroplasty effectiveness. Early signals show incremental weight loss gains compared to suturing alone, with regulatory pathways in the pipeline for broader adoption. 

• June 2025: Allurion Technologies secured a strategic partnership with a major Indian hospital chain to introduce Elipse™ in over 50 centers nationwide, aiming to reach 10,000 patients annually. This pact marks a significant expansion of their role in the Non-Surgical Obesity Treatment Devices Market within the Asia-Pacific region. 

 

“Non-Surgical Obesity Treatment Devices Production Data and Non-Surgical Obesity Treatment Devices Production Trend”

• • • Non-Surgical Obesity Treatment Devices sales database for historical years, 10 years historical data
    • Non-Surgical Obesity Treatment Devices sales data and forecast for next 7 years

 

Key Insights that the Non-Surgical Obesity Treatment Devices Market analysis report presents are:

• Non-Surgical Obesity Treatment Devices Market revenue and demand by countries
• Non-Surgical Obesity Treatment Devices Market production and sales volume by countries
• Break-down of the Non-Surgical Obesity Treatment Devices Market in terms of application areas, target customers, and other potential market segments
• Areas that are relatively more potential and are faster growing
• Non-Surgical Obesity Treatment Devices Market competitive scenario, market share analysis
• Non-Surgical Obesity Treatment Devices Market business opportunity analysis

Global and Country-Wise Non-Surgical Obesity Treatment Devices Market Statistics

• Global and Country-Wise Non-Surgical Obesity Treatment Devices Market size ($Million) and Forecast – (2021 – 2028)
• Global and Country-Wise Non-Surgical Obesity Treatment Devices Market Production Volume and Forecast – (2021 – 2028)
• Global and Country-Wise Non-Surgical Obesity Treatment Devices Market Sales Volume and Forecast – (2021 – 2028)
• Global and Country-Wise Non-Surgical Obesity Treatment Devices Market Business Opportunity Assessment